Development of a zebrafish sepsis model for high-throughput drug discovery.

Abstract excerpt

Sepsis is a leading cause of death worldwide. Current treatment modalities remain largely supportive. Intervention strategies focused on inhibiting specific mediators of the inflammatory host response have been largely unsuccessful, a consequence of an inadequate understanding of the complexity and heterogeneity of the innate immune response. Moreover, the conventional drug development pipeline is time consuming...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug Discovery
• Share to Embryo, Nonmammalian